X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (86) 86
female (70) 70
male (64) 64
rheumatology (62) 62
middle aged (53) 53
adult (51) 51
index medicus (38) 38
cohort studies (24) 24
article (23) 23
lupus erythematosus, systemic - ethnology (23) 23
systemic lupus erythematosus (23) 23
severity of illness index (21) 21
aged (20) 20
african americans (17) 17
longitudinal studies (17) 17
3 ethnic-groups (16) 16
classification (16) 16
european continental ancestry group (16) 16
risk factors (16) 16
hispanic americans (15) 15
ethnicity (14) 14
lupus erythematosus, systemic - complications (14) 14
prevalence (14) 14
clinical medicine (13) 13
medical and health sciences (13) 13
medicin och hälsovetenskap (13) 13
disease progression (12) 12
disease-activity (12) 12
klinisk medicin (12) 12
quality of life (12) 12
reumatologi och inflammation (12) 12
revised criteria (12) 12
rheumatology and autoimmunity (12) 12
scleroderma (12) 12
treatment outcome (12) 12
abridged index medicus (11) 11
disease (11) 11
predictors (11) 11
risk-factors (11) 11
double-blind method (10) 10
ethnic groups (10) 10
prospective studies (10) 10
socioeconomic-status (10) 10
united states - epidemiology (10) 10
autoantibodies (9) 9
lupus (9) 9
lupus erythematosus, systemic - epidemiology (9) 9
mortality (9) 9
systemic sclerosis (9) 9
care and treatment (8) 8
follow-up studies (8) 8
index (8) 8
lupus erythematosus, systemic - diagnosis (8) 8
multivariate analysis (8) 8
regression analysis (8) 8
rheumatoid-arthritis (8) 8
vasculitis (8) 8
case-control studies (7) 7
lupus erythematosus, systemic - physiopathology (7) 7
nephritis (7) 7
race (7) 7
studies (7) 7
survival (7) 7
systemic scleroderma (7) 7
time factors (7) 7
young adult (7) 7
aged, 80 and over (6) 6
anti-neutrophil cytoplasmic antibody-associated vasculitis - drug therapy (6) 6
antibodies (6) 6
association (6) 6
clinical-assessment (6) 6
cyclophosphamide - therapeutic use (6) 6
european continental ancestry group - statistics & numerical data (6) 6
immunosuppressive agents - therapeutic use (6) 6
internationality (6) 6
knee osteoarthritis (6) 6
long-term (6) 6
outcomes (6) 6
pain measurement (6) 6
proportional hazards models (6) 6
reliability (6) 6
therapy (6) 6
wegeners-granulomatosis (6) 6
african americans - statistics & numerical data (5) 5
antiphospholipid antibodies (5) 5
arthritis (5) 5
autoimmune diseases (5) 5
cyclophosphamide (5) 5
disability evaluation (5) 5
discordance (5) 5
dna - immunology (5) 5
drug therapy (5) 5
epidemiology (5) 5
genetics (5) 5
health status (5) 5
immunosuppressive agents - administration & dosage (5) 5
immunosuppressive agents - adverse effects (5) 5
lumina (5) 5
lupus erythematosus, systemic - drug therapy (5) 5
lupus erythematosus, systemic - immunology (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Best Practice & Research: Clinical Rheumatology, ISSN 1521-6942, 2013, Volume 27, Issue 1, pp. 1 - 2
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 11/2013, Volume 72, Issue 11, pp. 1747 - 1755
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 5, pp. 417 - 427
This study of ANCA-associated vasculitis compared a single course of rituximab with conventional immunosuppression with cyclophosphamide followed by... 
WEGENERS-GRANULOMATOSIS | MAINTENANCE | MEDICINE, GENERAL & INTERNAL | ANTIBODY-ASSOCIATED VASCULITIS | RENAL VASCULITIS | CYCLOPHOSPHAMIDE | RITUXIMAB | ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES | RANDOMIZED-TRIAL | SYSTEMIC VASCULITIDES | CELL-ACTIVATION | Recurrence | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Double-Blind Method | Drug Administration Schedule | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Immunologic Factors - administration & dosage | Kaplan-Meier Estimate | B-Lymphocytes | Rituximab | Cyclophosphamide - adverse effects | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Cyclophosphamide - therapeutic use | Immunosuppressive Agents - adverse effects | Immunologic Factors - adverse effects | Drug Therapy, Combination | Antibodies, Monoclonal, Murine-Derived - adverse effects | Azathioprine - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use | Immunosuppression | Vasculitis | Drug therapy | Patient outcomes | Disease | Medical treatment | Hypersensitivity | Patients | Immunosuppressive agents | Cyclophosphamide | Infectious diseases | Lymphocytes B | Antineutrophil cytoplasmic antibodies | Remission | Azathioprine
Journal Article
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 09/2015, Volume 74, Issue 9, pp. 1706 - 1713
Journal Article
Rheumatic Disease Clinics of North America, ISSN 0889-857X, 2010, Volume 36, Issue 3, p. 13
Journal Article
Journal Article
Journal Article
Rheumatology (United Kingdom), ISSN 1462-0324, 10/2015, Volume 55, Issue 2, pp. 252 - 262
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 07/2015, Volume 67, Issue 7, pp. 1837 - 1847
Journal Article
by Mayes, Maureen D and Bossini-Castillo, Lara and Gorlova, Olga and Martin, José Ezequiel and Martin, Javier and Zhou, Xiaodong and Chen, Wei V and Assassi, Shervin and Ying, Jun and Tan, Filemon K and Arnett, Frank C and Reveille, John D and Guerra, Sandra and Teruel, María and Carmona, Francisco David and Gregersen, Peter K and Lee, Annette T and López-Isac, Elena and Ochoa, Eguzkine and Carreira, Patricia and Simeón, Carmen Pilar and Castellví, Iván and González-Gay, Miguel Ángel and Ortego-Centeno, Norberto and Ríos, Raquel and Callejas, José Luis and Navarrete, Nuria and García Portales, Rosa and Camps, María Teresa and Fernández-Nebro, Antonio and González-Escribano, María F and Sánchez-Román, Julio and García-Hernández, Francisco José and Castillo, María Jesús and Aguirre, María Ángeles and Gómez-Gracia, Inmaculada and Fernández-Gutiérrez, Benjamín and Rodríguez-Rodríguez, Luis and Vicente, Esther and Andreu, José Luis and Fernández de Castro, Mónica and García de la Peña, Paloma and López-Longo, Francisco Javier and Martínez, Lina and Fonollosa, Vicente and Espinosa, Gerard and Tolosa, Carlos and Pros, Anna and Rodríguez Carballeira, Mónica and Narváez, Francisco Javier and Rubio Rivas, Manel and Ortiz Santamaría, Vera and Díaz, Federico and Díaz, Bernardino and Trapiella, Luis and Freire, María del Carmen and Sousa, Adrián and Egurbide, María Victoria and Fanlo Mateo, Patricia and Sáez-Comet, Luis and Hernández, Vanesa and Beltrán, Emma and Román-Ivorra, José Andrés and Grau, Elena and Alegre Sancho, Juan José and Blanco García, Francisco J and Oreiro, Natividad and Fernández Sueiro, Luis and Zhernakova, Alexandra and Padyukov, Leonid and Alarcón-Riquelme, Marta and Wijmenga, Cisca and Brown, Matthew and Beretta, Lorenzo and Riemekasten, Gabriela and Witte, Torsten and Hunzelmann, Nicolas and Kreuter, Alexander and Distler, Jörg H.W and Voskuyl, Alexandre E and Schuerwegh, Annemie J and Hesselstrand, Roger and Nordin, Annika and Airó, Paolo and Lunardi, Claudio and Shiels, Paul and van Laar, Jacob M and Herrick, Ariane and Worthington, Jane and Denton, Christopher and Wigley, Fredrick M and Hummers, Laura K and Varga, John and Hinchcliff, Monique E and Baron, Murray and Hudson, Marie and Pope, Janet E and Furst, Daniel E and Khanna, Dinesh and Phillips, Kristin and ... and Spanish Scleroderma Grp and Spanish Scleroderma Group and Department of Rheumatology and Lund University and Reumatologi och molekylär skelettbiologi and Lunds universitet
The American Journal of Human Genetics, ISSN 0002-9297, 01/2014, Volume 94, Issue 1, pp. 47 - 61
In this study, 1,833 systemic sclerosis (SSc) cases and 3,466 controls were genotyped with the Immunochip array. Classical alleles, amino acid residues, and... 
FUNCTIONAL POLYMORPHISM | DNASE-GAMMA | VARIANTS | DISEASE | GENETICS & HEREDITY | STAT4 | WHOLE-GENOME ASSOCIATION | GENETIC RISK-FACTOR |